Deflazacort

Deflazacort, a glucocorticoid, is an inactive proagent and is converted rapidly to the active metabolite 21-desacetyldeflazacort. Deflazacort is used as an anti-inflammatory and immunosuppressant[1].

Product Specifications

CAS Number

[14484-47-0]

UNSPSC

12352005

Hazard Statement

H315, H319, H320

Target

Glucocorticoid Receptor

Type

Reference compound

Related Pathways

Immunology/Inflammation; Vitamin D Related/Nuclear Receptor

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Endocrinology

Assay Protocol

https://www.medchemexpress.com/Deflazacort.html

Concentration

10mM

Purity

99.84

Solubility

DMSO : ≥ 100 mg/mL

Smiles

O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@]5([H])[C@@]4(C(COC(C)=O)=O)N=C(C)O5)=C1

Molecular Formula

C25H31NO6

Molecular Weight

441.52

Precautions

H315, H319, H320

References & Citations

[1]Mollmann, H., et al., Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone. Pharmaceutical research, 1995. 12 (7) : p. 1096-1100.